Pradaxa Attorney Notes: First of Four Trials Has Been Scheduled for September
Those who have filed Pradaxa lawsuits after allegedly experiencing life-threatening side effects such as internal bleeding may be one step closer to arguing their cases in court. According to court documents, the first of four bellwether Pradaxa trials is scheduled to begin in September 2014.
If you or someone you love experienced complications that you feel were caused by Pradaxa or if you have questions about the pending Pradaxa trials, contact a Pradaxa attorney today. The American Injury Attorney Group can inform you of your legal rights and connect you with an experienced Pradaxa attorney to file your lawsuit.
First of Four Pradaxa Trials Scheduled
The first of four Pradaxa trials is slated to begin September 15, 2014 in the U.S. District Court, Southern District of Illinois, according to a recent Case Management Order. The second of the Pradaxa trials is expected to start on December 1, 2014. The third will follow on February 17, 2015, and the final of the bellwether trials will tentatively begin on March 23, 2015, the Order indicates.
Each case in the Pradaxa trials similarly allege episodes of internal bleeding as well as other side effects allegedly caused by Pradaxa. Additionally, at least 2,230 Pradaxa lawsuits have now been filed in the federal proceeding, according to a recent Case List update posted on the Court’s website. Those working with a Pradaxa attorney are interested in these bellwether trials as these cases will provide the opportunity for both parties to evaluate the possible future outcomes of Pradaxa lawsuits.
Some Pradaxa lawsuits pending in the U.S. Southern District of Illinois allege that the drug’s manufacturer, Boehringer-Ingelheim, failed to warn physicians and patients of the potential side effects associated with the medication. Plaintiffs working with a Pradaxa attorney allege that the medication, introduced in 2010, may cause gastrointestinal bleeding, cerebral hemorrhage and other severe episodes of internal bleeding.
Furthermore, plaintiffs allege that the manufacturer failed to provide an antidote to stop episodes of bleeding once they begin, making these complications life threatening. Since it was first introduced in the U.S., Pradaxa is prescribed to prevent heart attacks and strokes in patients with atrial fibrillation and has been marketed as an alternative to warfarin, the most well known blood thinner available today. However, episodes of internal bleeding while taking warfarin may be reversed with an administration of vitamin K, whereas they cannot be reversed for Pradaxa.
Between 2011 and 2012, 12,494 injury reports and 1,158 claims of death were sent to the U.S. Food and Drug Administration, according to reports. The investigation also found that no other prescription medication was associated with as many adverse events.
However, despite these reports of death and injury, the FDA issued a Drug Safety Communication in November 2012 to announce that the agency assessed bleeding rates of both Pradaxa and warfarin and found that those taking the former were not necessarily at an increased risk of internal bleeding or other complications. The agency then announced in December 2013 that it would be launching a new, large-scale assessment of these risks in relation to warfarin. The results have not yet been released.
Injured? A Pradaxa Attorney Can Help
If you or a loved one have taken Pradaxa and subsequently suffered from adverse side effects or complications, or if you have questions about the scheduled Pradaxa trials, consider seeking legal counsel from a Pradaxa attorney. The American Injury Attorney Group provides free case evaluations to those who feel they have a valid claim. We will connect you with an affiliated Pradaxa attorney who can assist you in seeking the compensation to which you may be entitled. The statute of limitations applies in many personal injury cases, so it is important to seek legal counsel as soon as possible.